UNNAMED from 'enafarm®' to 'enterosan®' - Electronic medicinal guide TALKDRUGS

Tablets of 10 mg and 20 mg.

Tablets 25 mg + 10 mg.

Lyophilizate for the preparation of a solution for subcutaneous administration, 10 mg.

Solution for subcutaneous administration, 50 mg / ml.

Lyophilizate for the preparation of a solution for subcutaneous administration, 25 mg.

Tablets are sublingual homeopathic.

Suspension for intramuscular injection, 20 μg / ml.

Powder for the preparation of a solution for intravenous administration of 200 mg, 500 mg, 1000 mg.

Tablets of 50 mg.

Powder for the preparation of a suspension for oral administration [orange, vanilla], 3 g.

Powder for solution for oral administration.

Solution for rectal administration.

The tablets covered with a cover, 200 mg.

Solution for intraamnial administration 5 mg / ml.

Tablets set: indapamide, tablets, film-coated, 2.5 mg + enalapril, 10 mg tablets.

Hemofarm AD Serbia

Tablets set: indapamide, film-coated tablets, 2.5 mg + enalapril, tablets 10 mg.

Hemofarm AD Serbia

Tablets set: indapamide, tablets, film-coated, 2.5 mg + enalapril, 20 mg tablets.

Hemofarm AD Serbia
Tablets, covered with enteric coating.
Tablets, covered with enteric coating.

Solution for injection 10,000 anti-Xa ME (100 mg) / ml.

Tablets, coated with enteric coating, 200 mg and 300 mg.

Tablets of prolonged action, film-coated, 200 mg, 300 mg and 500 mg.

Solution for Injection 2000 anti-Ha IU / 0.2 ml; 4000 anti-Ha IU / 0.4 mL; 6000 anti-Ha IU / 0.6 mL; 8000 anti-Ha IU / 0.8 ml; 10,000 anti-Ha IU / 1 ml.

Powder for the preparation of a solution for subcutaneous administration is 250 μg, 500 μg (500 μg / ml).
Amgen Europe BV Netherlands

Tablets, film-coated, 0.5 mg and 1.0 mg.

Powder for the preparation of solution for ingestion.
5 grams per pack of material combined multilayer.

Powder for suspension for oral administration, 250 mg.

BIOCODEX France
Capsules 250 mg.
BIOCODEX France
Powder for suspension for oral administration, 100 mg.
BIOCODEX France
Capsules of 300 mg.